Peroxisome proliferator-activated receptor gamma and spermidine/spermine N1-acetyltransferase gene expressions are significantly correlated in human colorectal cancer

1471-2407-6-191 1471-2407 Research article Peroxisome proliferator-activated receptor gamma and spermidine/spermine N1-acetyltransferase gene expressions are significantly correlated in human colorectal cancer Linsalata Michele m.linsalata@libero.it Giannini Romina romina.giannini@libero.it Notarnicola Maria m.notarnicola@email.it Cavallini Aldo cavaldo@libero.it

Laboratory of Biochemistry, National Institute for Digestive Diseases, I.R.C.C.S. "Saverio de Bellis" via Della Resistenza, 70013-Castellana Grotte (BA), Italy

BMC Cancer 1471-2407 2006 6 1 191 http://www.biomedcentral.com/1471-2407/6/191 1685421610.1186/1471-2407-6-191 30 3 2006 19 7 2006 19 7 2006 2006 Linsalata et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

The peroxisome proliferator-activated receptor γ (PPARγ) is a transcription factor that regulates adipogenic differentiation and glucose homeostasis. Spermidine/spermine N¹-acetyltransferase (SSAT) and ornithine decarboxylase (ODC) are key enzymes involved in the metabolism of polyamines, compounds that play an important role in cell proliferation. While the PPARγ role in tumour growth has not been clearly defined, the involvement of the altered polyamine metabolism in colorectal carcinogenesis has been established. In this direction, we have evaluated the PPARγ expression and its relationship with polyamine metabolism in tissue samples from 40 patients operated because of colorectal carcinoma. Since it is known that the functional role of K-ras mutation in colorectal tumorigenesis is associated with cell growth and differentiation, polyamine metabolism and the PPARγ expression were also investigated in terms of K-ras mutation.

Methods

PPARγ, ODC and SSAT mRNA levels were evaluated by reverse transcriptase and real-time PCR. Polyamines were quantified by high performance liquid chromatography (HPLC). ODC and SSAT activity were measured by a radiometric technique.

Results

PPARγ expression, as well as SSAT and ODC mRNA levels were significantly higher in cancer as compared to normal mucosa. Tumour samples also showed significantly higher polyamine levels and ODC and SSAT activities in comparison to normal samples. A significant and positive correlation between PPARγ and the SSAT gene expression was observed in both normal and neoplastic tissue (r = 0.73, p < 0.0001; r = 0.65, p < 0.0001, respectively). Moreover, gene expression, polyamine levels and enzymatic activities were increased in colorectal carcinoma samples expressing K-ras mutation as compared to non mutated K-ras samples.

Conclusion

In conclusion, our data demonstrated a close relationship between PPARγ and SSAT in human colorectal cancer and this could represent an attempt to decrease polyamine levels and to reduce cell growth and tumour development. Therefore, pharmacological activation of PPARγ and/or induction of SSAT may represent a therapeutic or preventive strategy for treating colorectal cancer.

Background

The peroxisome proliferator-activated receptor γ (PPARγ) is a member of the nuclear receptor superfamily 1 . It functions as a transcription factor, heterodimerizes with the retinoid X receptor (RXR) and regulates the expression of target genes by binding to the PPAR response elements (PPERs). The PPARγ, initially identified for its role in the metabolism and adipocyte differentiation, is also expressed in tissue outside the adipocyte lineage, including colonic epithelia 2 . In cancer biology PPARγ is the most intensively studied PPAR isoform and several studies have shown the protective role of this nuclear receptor in colorectal tumour 3 . On the contrary, other authors have questioned the antineoplastic activity of PPARγ ligands 4 . In addition, although most of the known target genes activated by PPARγ belong to the pathway of metabolism and lipid transport, the target genes mediating the pro- or anti-cancer activity by affect of the activated PPARγ have not yet been identified.

Recently, Babbar et al. 5 demonstrated that in colorectal tumour cells, the promoter of spermidine/spermine N¹-acetyltransferase (SSAT) gene contains a functional PPAR responsive element and activated PPARγ is able to activate transcription of this gene.

SSAT and ornithine decarboxylase (ODC) are key enzymes involved in the catabolism and biosynthesis, respectively, of the polyamines (putrescine, spermidine and spermine), compounds that play an important role in both normal and neoplastic cell proliferation 6 . Increased ODC activity and the associated elevation in intracellular polyamines have been implicated in carcinogenesis of many human tissues, including those of the gastrointestinal tract 7 8 9 .

Induction of SSAT plays an important role in lowering the polyamine pool and typically gives rise to growth inhibition as well as exerting tumour-suppressive effects 10 11 . Particularly, Wallace et al. have hypothesized that the increase in SSAT activity may be an attempt to reduce the polyamine pool in tumour cells. 12

Little is know about the relationship between polyamine metabolism and PPARγ expression in colorectal tumours and available information is derived from in vitro studies 5 13 .

We have provided evidence about a close relationship between polyamine biosynthesis and K-ras mutation in human colorectal carcinoma 14 . Moreover, in the human colon adenocarcinoma cell line, it has been shown that mutated K-ras suppressed SSAT via a transcriptional mechanism that involves PPARγ signalling pathway 15 .

In order to investigate the relationship between PPARγ and polyamine metabolism in human colorectal carcinoma, the aim of this study was to evaluate the PPARγ, SSAT and ODC gene expression as well as polyamine levels and ODC and SSAT activities, in neoplastic samples and in surrounding uninvolved mucosa. The profile of polyamine metabolism and PPARγ mRNA expression were also investigated in relation to the presence of K-ras mutation in our tumour samples. We have exclusively focalised our attention on mutated codon 12 as it occurs more frequently in human colorectal cancer 16 .

Methods

Patients

Tissue samples were obtained at the time of surgical resection for colorectal adenocarcinoma from 40 patients: 24 men (mean age 64.8 years, range 36–88) and 16 women (mean age 64.4 years, range 28–87). Pieces of tissue were removed from the peripheral region of the tumour and surrounding mucosa in a region at least 10 cm from the neoplasm. The normal mucosa was found to be macroscopically and microscopically free of neoplastic growth. Immediately after removal, tissue was washed in cold saline solution and then rapidly (within 15–30 min) transported on ice to the laboratory and stored at -80°C until assay. The quality of the tumour and surrounding normal tissue specimens and the relative cellular composition were determined by histopathological assessment. The clinical and histopathological features of colorectal cancer patients are reported in Table 1. The design of this study was approved by the local ethics committee.

Table 1

Clinical and histopathological features of colorectal cancer patients (40 cases)

No of patients

sex

male

female

Location of tumour*

right

left

rectum

Dukes' stage

Differentiation grade§

*Right colon: caecum, ascending colon, hepatic flexure, transverse colon; left colon: splenic flexure, descending colon and sigmoid. § G1: well-differentiated, G2: moderately differentiated, G3: poorly differentiated.

Informed consent was obtained from all patients before their surgery and examination of specimens used in this study.

Analysis of the PPARγ, ODC and SSAT gene expression

PPARγ, ODC and SSAT mRNA levels were evaluated by reverse transcriptase and real-time PCR. The RNA isolation, reverse transcriptase and real-time PCR (RT-PCR) methods have been described previously 17 . In brief, after RNA extraction, aliquots of 5 μl of the reverse transcriptase reaction (20 μl), corresponding to 0.5 μg of total RNA, were subjected to the RT-PCR in 25 μl of final volume contained master mix (iQ SYBR Green Supermix, BioRad, Milan, Italy). The amplification program on a iCycler iQ Real-Time detection system (BioRad) was: 30 s at 95°C and then 10 s at 94°C, 10 s at 55°C and 30 s at 72°C for 45 cycles. A further melt-curve step (melt-curve started at 55°C and the temperature was increased 0.5°C per cycle for 80 cycles) was added in the thermocycler program at the end of the last extension phase of 45 cycles to control the presence of the secondary non specific PCR products or primer-dimer products. For quantitative analysis the external standard curves were used and the mRNA levels of each target gene were then normalized to those of the β-actin, as control gene.

The primers used were: 5'-AGGCGAGGGCGATCTTGACA-3' (forward primer) and 5'-ACCAGGAATGCTTTTGGCATACTCT-3' (reverse primer) for PPARγ (GenBak: NM_138712); 5'-GGTCCGCAAAGGGAAGAAA-3' and 5'-TGCCAATCCACGGGTCATA-3' for SSAT (GenBank: NM_002970); 5'-GATTCCAAAGCAGTCTGTCGTCTCA-3' and 5'-TTGTCCAACGCTGGGTTGATTACGC-3' for ODC (GenBank: M16650); 5'-AAGACCTGTACGCCAACACAGTGCTGTCTGG-3' and 5'-CGTCATACTCCTGCTTGCTGATCCACATCTGC-3' for β-actin (GenBank: NM_001101). The relative mRNA levels are expressed as target gene/β-actin ratio.

Polyamine analysis

Each tissue sample (approximately 10–15 mg) was homogenized in 700 μl of 0.9 percent sodium chloride mixed with 5 μl (174 μM) of the internal standard 1, 10-Diaminodecane (1, 10-DAD). In order to precipitate the proteins, 50 μl of perchloric acid (PCA) 3 M were added to the homogenate. After 30 minutes incubation in ice, the homogenate was centrifuged for 15 minutes at 7000 g. The supernatant was filtered (Millex-HV₁₃pore size 0.45 μm, Millipore, Bedford, MA) and lyophilized. The residue was dissolved in 250 μl of HCl (0.1 M). Aliquots (100 μl) were reacted with dansyl chloride and the dansyl-polyamine derivatives were determined by high performance liquid chromatography (HPLC) as previously described 7 . Polyamine levels were expressed as concentration values in nmol/g wet weight tissue.

ODC activity

ODC activity was measured with a radiometric technique as previously described 14 . In brief, the reaction mixture consists of DL-[1-¹⁴C]-ornithine and tissue extract in Tris-HCL buffer; the ¹⁴CO₂product generated by the enzyme reaction was trapped on filter paper pre-treated with NaOH, which was suspended in a center well above the reaction mixture. Radioactivity on the filter papers was determined by a liquid scintillation counter (model 1219 Rackbeta, LKB-Pharmacia, Uppsala, Sweden). ODC activity was expressed as pmol CO₂/h/mg of protein.

SSAT activity

SSAT activity was measured according to the method described by Wallace et al. 18 with minor modifications. The reaction was started by adding 70 μL of cytosol to a microfuge tube containing 30 μL of incubation buffer (30 mM spermidine, 0.1 μCi [acetyl-1-¹⁴C] acetyl coenzyme A, 1 M Tris-HCL, pH 7.8). The incubation was carried out for 10 min at 37°C, then 20 μL hydroxylamine hydrochloride were added to stop the reaction. The tubes were boiled for 3 min with pierced tops and then spun in a microfuge for 5 min. A quantity of 30 μL of supernatant was spotted on to Whatman P81 discs which were then washed five times with distilled water and three times with 100% ethanol. The radioactivity on the filter papers was determined by a liquid scintillation counter. SSAT activity was expressed as pmol of N¹-[¹⁴C] acetylspermidine generated/min/mg of protein.

K-ras mutation analysis

Genomic DNA was isolated from 50 mg of normal mucosa and tumour tissue by TRI-Reagent (Mol. Res. Centre Inc. Cincinnati, OH, USA) following manufacturer's instruction. The extracted DNA was dissolved in 50 μl of sterile water and used for PCR. Mutations in K-ras exon 1, codon 12 were screened by PCR amplification followed by RFLP analysis as previously described 14 .

Statistical analysis

Differences among polyamine levels, ODC activity, SSAT activity, and mRNA expression of relative genes were analyzed by Wilcoxon matched pairs test and Mann Whitney test when appropriate. The significance of differences, for the above parameters, in location of tumour, Dukes'stages, and differentiation grade was determined by Kruskal-Wallis analysis of variance. Correlations were evaluated by Spearman correlation test. All data are expressed as mean ± SEM. A p-value < 0.05 was considered as significant.

Results

The PPARγ, ODC and SSAT mRNA levels were significantly higher in colorectal carcinoma than in normal surrounding mucosa. In addition, polyamine levels, ODC and SSAT activities were significantly increased in neoplastic samples than in normal ones (p < 0.05; Wilcoxon matched pairs test) (Table 2). Of note, a significant and positive correlation between PPARγ and SSAT gene expression was observed in both normal and neoplastic tissue (r = 0.73, p < 0.0001; r = 0.65, p < 0.0001, respectively; Spearman correlation coefficient) (Figure 1).

Table 2

Polyamine levels, enzymatic activities and genes expression in normal and neoplastic colorectal tissues

Normal

Neoplastic

Putrescine

18.74 ± 3.1

50.87 ± 10.5

0.001

Spermidine

150.1 ± 10.6

302.2 ± 27.8

<0.0001

Spermine

387.3 ± 27.98

538.0 ± 41.7

0.003

Total polyamines

556.2 ± 39.9

891.0 ± 70.7

0.0002

ODC

21.2 ± 3.5

274.2 ± 70.9

<0.0001

SSAT

27.4 ± 3.8

40.4 ± 5.0

0.030

ODC mRNA

12.5 ± 2.0

20.7 ± 5.0

0.020

SSAT mRNA

2.7 ± 0.3

13.6 ± 1.5

<0.0001

PPARγ mRNA

0.3 ± 0.05

2.8 ± 0.5

<0.0001

Polyamines are reported as nmol/g wet tissue. ODC activity is expressed as pmol ¹⁴CO₂/h/mg of protein. SSAT activity is expressed as pmol N¹-[¹⁴C] acetylspermidine/min/mg of protein. The relative mRNA levels are expressed as target gene/β-actin ratio. All data are presented as mean ± SEM (Wilcoxon matched pairs test).

Figure 1

Representative correlations between PPARγ and SSAT mRNA expression in colorectal tissue

Representative correlations between PPARγ and SSAT mRNA expression in colorectal tissue. A. PPARγ mRNA expression correlates with that of SSAT mRNA levels in the normal mucosa samples of 40 patients (r = 0.73, p < 0.0001; Spearman correlation coefficient). B. PPARγ mRNA expression correlates with that of SSAT mRNA levels in the tumour tissue samples of 40 patients (r = 0.65, p < 0.0001, Spearman correlation coefficient). The relative mRNA levels are expressed as target gene/β-actin ratio.

K-ras codon 12 mutation was found in 12 out of 40 patients (30%). PPARγ expression, as well as ODC and SSAT mRNA levels were significantly higher (p < 0.05; Mann Whitney test) in colorectal carcinoma samples expressing K-ras mutation as compared to non mutated K-ras samples. Mutated K-ras tissues also showed significantly higher (p < 0.05) polyamine levels, as well as ODC and SSAT activities, as compared to non mutated K-ras tissues (Table 3).

Table 3

Polyamine levels, enzymatic activities and genes expression in neoplastic colorectal tissue with and without K-ras mutation.

Mutated K-ras n = 12

Non mutated K-ras n = 28

Putrescine

64.4 ± 14.7

41.0 ± 14.5

0.039

Spermidine

376.1 ± 49.2

248.8 ± 26.9

0.021

Spermine

652.2 ± 48.6

455.5 ± 55.99

0.020

Total polyamines

1093.0 ± 98.0

745.3 ± 85.5

0.012

ODC

525.1 ± 157.6

92.9 ± 26.5

0.002

SSAT

43.1 ± 5.6

25.92 ± 4.3

0.035

ODC mRNA

21.3 ± 4.4

8.79 ± 1.8

0.020

SSAT mRNA

18.0 ± 3.9

7.3 ± 1.4

0.011

PPARγ mRNA

2.9 ± 1.1

0.78 ± 0.2

0.032

The gene expression, the polyamine levels and the enzymatic activities were not associated with age, sex, tumour site, histological differentiation, and Dukes' stage (data not shown).

Discussion

Several studies have described increased or decreased levels of PPARγ expression in different human tumour tissue as compared to normal mucosa 19 20 21 . Hence, taking into consideration the diversity of human cancer, the expression of PPARγ may likely be dependent on tissue specificity and/or mutational events that are prerequisite for cancer development. In our study, real time RT-PCR analysis demonstrates a significant enhancement in the expression of PPARγ in colorectal tumours as compared to normal surrounding mucosa. Few studies have investigated the expression of PPARγ in human colorectal carcinoma in relation to normal mucosa. Previously, the comparison of PPARγ expression levels in 11 human colon adenocarcinomas revealed no change in comparison to normal mucosa 22 . In a recent study an increase of PPARγ expression in comparison to normal mucosa it has been observed in 25% (four) of patients with colorectal tumour 23 These contrasting results could be attributed to differences in methodological procedures as well as to the number of patients analyzed. With regard to the role of PPARγ in colon cancer, the available data are conflicting and mostly obtained in cell lines or in animal models 24 25 26 27 . On the other hand, it is well known that polyamine metabolism is an integral component of the mechanism of colorectal carcinogenesis 9 28 . In this study, a close and positive correlation was observed between the PPARγ and SSAT expression both in normal and neoplastic human colorectal tissues. Studies performed with colorectal tumour cell lines have shown that cells transfected with the PPARγ restored the SSAT promoter activity, and an activated PPARγ could increase SSAT expression in these cells 15 . Thus, our findings in human tissue are compatible with the in vitro studies about the transcriptional induction of PPARγ on the SSAT gene.

In the light of these data, we suggest that, in colorectal normal mucosa, PPARγ induces SSAT expression and influences polyamine availability, regulating cell proliferation and differentiation. In fact, it is known that the requirement of polyamines in cell growth is typically met by a biosynthetic pathway regulated by ODC and balanced by a polyamine catabolic pathway regulated by SSAT 29 .

In colorectal tumour tissue, we observed an increase in PPARγ and SSAT expression as well as in SSAT activity.

The relationship between SSAT and cancer is only now being defined. In this respect, in vitro and in vivo studies are consistent with the notion that SSAT suppresses cell growth and tumour development 30 31 . On the contrary, a Min mouse model in which SSAT expression promotes tumorigenesis has been proposed. 32 . Furthermore, the role of SSAT in the polyamine metabolism in the cancer tissue seems to be tissue dependent. In fact, it has been observed that the increase in SSAT activity leads to polyamine pool depletion and growth inhibition in breast tumour 12 33 .

On the other hand, in prostatic cancer the SSAT overexpression induces growth inhibition without determining polyamine pool depletion since SSAT activity seems to modulate ODC activity 11 34 .

In this study, we report both higher polyamine levels and ODC activity in neoplastic tissue samples than in normal ones, thus confirming our previous data and those of other groups obtained in human colorectal cancer or in other types of carcinoma 35 36 37 38 39 .

We have also found that while colon cancer tissue exhibits about a 13-fold increase of the ODC activity in comparison to normal tissue, SSAT activity rises by 1.5-fold only. The tumour polyamine pool seems to be maintained at higher levels by a robust increase in ODC activity not properly balanced by a severe increase in SSAT activity. Therefore, the SSAT response could be secondary to a pro-cancerous increase in ODC activity and polyamine levels. In this direction, we can suppose that the increase in polyamine catabolic activity, as a result of PPARγ induction without a concomitant downregulation of the polyamine biosynthetic pathway, could be insufficient for counteracting tumour development.

Our findings about PPARγ and polyamine metabolism in mutated K-ras colorectal cancer seem to follow this direction. In fact, we have detected higher levels of PPARγ and SSAT expression, as well as higher SSAT activity, in mutated K-ras samples. These data suggest that in cancer tissue with high rate of proliferation and likely with enhanced polyamine levels and ODC activity 14 , there is an attempt to restore a growth control via SSAT with a mechanism involving PPARγ. However, in a vitro study, it has been shown that mutated K-ras suppressed the SSAT expression via a transcriptional mechanism involving the PPARγ signalling pathway 15 . The in vitro findings may not be directly relevant to the in vivo effects and different tumour models can result in diversified functional outcome.

Conclusion

In conclusion, our data show a close relationship between PPARγ and SSAT in human colorectal cancer and this could represent an attempt to decrease polyamine levels and to reduce cell growth and tumour development. These findings support the hypothesis that pharmacological activation of PPARγ and/or induction of SSAT may represent, in future, an effective therapeutic or preventive strategy for colorectal cancer. In this direction a therapeutic or chemopreventive approach using a combination of polyamine biosynthesis inhibitor like difluoromethylornithine (DFMO), and an agent, like a non-steroidal anti-inflammatory drug (NSAID) which induces catabolism, should be more efficacious than a single approach. This rationale has provided the basis of two ongoing chemoprevention studies 40 .

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

ML conceived the study, participated in the manuscript preparation and performed polyamine analysis and enzymatic activities assay. MN carried out the K-ras mutation analysis. RG carried out the tissue collection and real-time PCR analysis. AC, participated in the study design and in the manuscript preparation and elaborated the gene expression analysis. All authors have read and approved the final manuscript.

Acknowledgements

We thank Dr. Palma Carbonara (a native English speaking colleague) for revision of the English language.

We wish to thank Mrs Benedetta D'Attoma (Laboratory of Biochemistry, National Institute for Digestive Diseases, I.R.C.C.S. "S. de Bellis") for her excellent technical assistance.

This work was supported by grant 132/2002 from the Ministero della Salute, Rome, Italy.

PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth Rosen ED Spiegelman BM J Biol Chem 2001 276 37731 37734 Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells Lefebvre A-M Paulweber B Fajas L Woods J McCrary C Colombel J-F Najib J Fruchart J-C Datz C Vidal H Desreumaux P Auwerx J J Endocrinol 1999 162 331 334 Peroxisome proliferator-activated receptor γ and cancers Koeffler HP Clin Cancer Res 2003 9 1 9 Nuclear receptors. PPARγ in the gastrointestinal tract: gain or pain? Auwerx J Am J Physiol Gastrointest Liver Physiol 2002 282 G581 G585 Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer Babbar N Ignatenko NA Casero RA Gerner EW J Biol Chem 2003 278 47762 47775 Polyamine metabolism and cancer Thomas T Thomas TJ J Cell Mol Med 2003 7 113 126 Prognostic value of tissue polyamine levels in human colorectal carcinoma Linsalata M Caruso MG Leo S Guerra V D'Attoma B Di Leo A Anticancer Res 2002 22 2465 2470 Genetic and biochemical changes in colorectal carcinoma in relation to morphologic characteristics Notarnicola M Linsalata M Caruso M Caruso ML Altomare D Lorusso D Leo S Di Leo A Oncol Rep 2003 10 1987 1991 Polyamines and colon cancer Milovic V Turchanowa L Biochem Soc Trans 2003 31 381 383 Catabolism of polyamines Seiler N Amino Acids 2004 26 217 233 Activated polyamine catabolism depletes acetyl-CoA pools and suppresses prostate tumor growth in TRAMP mice Kee K Foster BA Merali S Kramer DL Hensen ML Diegelman P Kisiel N Vujcic S Mazurchuk RV Porter CW J Biol Chem 2004 38 40076 40083 Alterations in polyamine catabolic enzymes in human breast cancer tissue Wallace HM Duthie J Evans DM Lamond S Nicoll KM Heyes SD Clin Cancer Res 2000 6 3657 3661 PPAR-γ ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity Takashima T Fujiwara Y Higuchi K Arakawa T Yano Y Hasuma T Int J Oncol 2001 19 465 471 Polyamine biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma Linsalata M Notarnicola M Caruso MG Di Leo A Guerra V Russo F Scand J Gastroenterol 2004 39 470 477 Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cells Ignatenko NA Babbar N Mehta D Casero RA Gerner EW Mol Carcinog 2004 39 91 102 Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancer Bleeker WA Hayes VM Karrenbeld A Hofstra RM Verlind E Hermans J Poppema S Buys CH Plukker JT Dis Colon Rectum 2001 44 358 363 Expression analysis of a subset of coregulators and three nuclear receptors in human colorectal carcinoma Giannini R Cavallini A Anticancer Res 2005 25 4287 4292 Measurement of spermidine/spermine N1-acetyltransferase activity Wallace HM Evans DM Methods in molecular biology Totowa: Humana Press Inc David ML Morgan 1998 79 59 68 Evaluation of peroxisome proliferator-activated receptor-gamma expression in benign and malignant thyroid pathologies Karger S Berger K Eszlinger M Tannapfel A Dralle H Paschke R Fuhrer D Thyroid 2005 15 997 1003 Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma Zhang GY Ahmed N Riley C Oliva K Barker G Quinn MA Rice GE Br J Cancer 2005 92 113 119 Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer Therashita Y Sasaki H Haruki N Nishiwaki T Ishiguro H Shibata Y Kudo J Konishi S Kato J Koyama H Kimura M Sato A Shinoda N Kuwabara Y Fujii Y Jpn J Clin Oncol 2002 32 238 243 Differentiation and reversal of malignant changes in colon cancer through PPARγ Sarraf P Mueller E Jones D King FJ DeAngelo DJ Partridge JB Holden SA Chen LB Singer S Fletcher C Spiegelman BM Nat Med 1998 4 1046 1052 Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARγ-coactivator 1 (PGC-1) Feilchenfeldt J Brundler MA Soravia C Totsch M Meier CA Cancer Lett 2004 203 25 33 The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers DuBois R Gupta R Brockman J Reddy BS Krakow SL Lazar MA Carcinogenesis 1998 19 49 53 Activation of the peroxisome proliferator activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+mice Lefebvre AM Chen I Desreumaux P Naijb J Fruchart JC Geboes K Briggs M Heyman R Auwerx J Nat Med 1998 4 1053 1057 Characteristics of peroxisome proliferators-activated receptor gamma (PPARγ) ligand induced apoptosis in colon cancer cells Shimava T Kojima K Yoshiura K Hiraishi H Terano A Gut 2002 50 658 664 Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands Kohno H Suzuki R Sugie S Tanaka T BMC Cancer 2005 5 46 Effects of genistein on the polyamine metabolism and cell growth in DLD-1 human colon cancer cells Linsalata M Russo F Notarnicola M Guerra V Cavallini A Clemente C Messa C Nutr and Cancer 2005 52 83 92 Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications Thomas T Thomas TJ Cell Mol Life Sci 2001 58 244 258 Small interfering RNA suppression of polyamine analog-induced spermidine/spermine N1-acetyltransferase Chen Y Kramer DL Jell j Vujcic S Porter CW Mol Pharmacol 2003 64 1153 1159 Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells Kee K Vujcic S Merali S Diegelman P Kisiel N Powell CT Kramer DL Porter CW J Biol Chem 2004 279 27050 27058 Potent modulation of intestinal tumorigenesis in Apcmin/+ mice by the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase Tucker JM Murphy JT Kisiel N Diegelman P Barbour KW Davis C Medda M Alhonen L Janne J Kramer DL Porter CW Berger FG Cancer Res 2005 65 5390 5398 Effects of conditional of overexpression of spermidine-spermine N1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs Vujcic S Halmekyto M Diegelman p Gan G Kramer DL Janne J Porter CW J Biol Chem 2000 275 38319 38328 Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells Kee K Vujcic S Merali S Diegelman P Kisiel N Powell CT Kramer DL Porter CW J Biol Chem 2004 279 27050 27058 Polyamines, diamine oxidase, and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa Linsalata M Russo F Cavallini A Berloco P Di Leo A Dis Colon Rectum 1993 36 662 667 Polyamine oxidase activity and polyamine levels in human colorectal cancer and in normal surrounding mucosa Linsalata M Cavallini A Di Leo A Anticancer Res 1997 17 3757 3760 Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and grade Weiss T Bernhardt G Buschauer A Thasler WA Dolgner D Zirngibl H Jauch KW Int J Colorectal Dis 2002 17 381 387 Polyamines levels in colorectal cancer: new markers? Naso P Lantieri R Acquaviva R Licata F Bonanno G Licata A Hepatogastroenterol 2005 52 433 436 Polyamine levels and ODC activity in intestinal-type and diffuse-type gastric carcinoma Russo F Linsalata M Giorgio I Caruso ML Armentano R Di Leo A Dig Dis Sci 1997 42 576 579 Emerging concepts in targeting thepolyamine metabolic pathway in epithelial cancer chemoprevention and chemotherapy Basuroy UK Gerner EW J Biochem 2006 139 27 33

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2407/6/191/prepub